Nyxoah (NYXH) Return on Capital Employed (2022 - 2026)
Nyxoah (NYXH) posted quarterly Return on Capital Employed of 34490.39% for Q1 2026, down 5056009.0% year-over-year from N/an in Q1 2025, and down 282.1% quarter-over-quarter from 18940.54% in Q2 2025.
Nyxoah (NYXH) Return on Capital Employed (2022 - 2026) Analysis & Trends
Nyxoah's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 34490.39% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 5056009.0% year-over-year to 34490.39%; the TTM figure through Mar 2026 stood at 34490.39% (down 5056009.0% YoY), while the FY2025 annual figure was 100.58%, down 5165.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 34490.39%, down from 18940.54% in the prior quarter.
- The five-year high for Return on Capital Employed was 25603.25% in Q4 2024, with the low at 34490.39% in Q1 2026.
- The 5-year median for Return on Capital Employed is 12683.71% (2025), against an average of 9978.39%.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed surged 2065875 bps in 2023, then sank 5056009 bps in 2026.
- Nyxoah's Return on Capital Employed stood at 11.84% in 2022, then surged by 174504 bps to 20646.91% in 2023, then rose by 24 bps to 25603.25% in 2024, then slipped by 26 bps to 18940.54% in 2025, then plunged by 282 bps to 34490.39% in 2026.
- Business Quant data shows NYXH's Return on Capital Employed at 34490.39% in Q1 2026, 18940.54% in Q2 2025, and 16069.71% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | -27,154.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41,692.48% |
| Mar 31, 2026 | -34,490.39% |
| Jun 30, 2025 | 18,940.54% |
| Mar 31, 2025 | 16,069.71% |
| Dec 31, 2024 | 25,603.25% |
| Sep 30, 2024 | 19,362.10% |
| Jun 30, 2024 | 22,215.99% |
| Mar 31, 2024 | 24,293.36% |
| Dec 31, 2023 | 20,646.91% |
| Sep 30, 2023 | 9,297.72% |
| Jun 30, 2023 | 8,830.47% |
| Mar 31, 2023 | 8,948.71% |
| Dec 31, 2022 | -11.84% |
| Sep 30, 2022 | 0.08% |
| Mar 31, 2022 | -9.13% |